Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 7/2014

01.07.2014 | Original Article – Clinical Oncology

Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients

verfasst von: A. C. Conrad, K. Muenstedt, O. Micke, F. J. Prott, R. Muecke, J. Huebner

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

A high proportion of cancer patients use complementary and alternative medicine (CAM). In oncology, risks of CAM are side effects and interactions.

Objective

Our aim was to conduct a survey on professionals in palliative care regarding attitudes toward CAM.

Design and subjects

An internet-based survey with a standardized questionnaire was sent to all members of the German Society for Palliative Care.

Measurements

The questionnaire collected data on attitude toward CAM and experiences.

Results

Six hundred and ninety questionnaires (19 %) were returned (49 % physicians, 35 % nurses, 3 % psychologists). Acceptance of CAM is high (92 % for complementary and 54 % for alternative medicine). Most participants had already been asked on CAM by patients (95 %) and relatives (89 %). Forty-four percent already had used complementary methods and 5 % alternative methods. Only 21 % think themselves adequately informed. Seventy-four percent would use complementary methods in a patient with advanced tumor, and 62 % would use alternative therapy in patients if there was no other therapy. Even from those who are skeptical 45 % would treat a patient with alternative methods.

Conclusions

In order to inform patients on CAM and to further patients’ autonomy, evidence on benefits and harms of CAM must be provided. As awareness of risks from CAM is low and critical appraisal especially of alternative medicine missing, but interest on information on CAM is high, experts should provide evidence-based recommendations for CAM in palliative care to members of different professions. This could be done by a curriculum focusing on the most often used CAM methods.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Boddy K, Ernst E (2008) Review of reliable information sources related to integrative oncology. Hematol Oncol Clin North Am 22: 619–30, vii Boddy K, Ernst E (2008) Review of reliable information sources related to integrative oncology. Hematol Oncol Clin North Am 22: 619–30, vii
Zurück zum Zitat Davidson R, Geoghegan L, McLaughlin L (2005) Psychological characteristics of cancer patients who use complementary therapies. Psychooncology 14:187–195PubMedCrossRef Davidson R, Geoghegan L, McLaughlin L (2005) Psychological characteristics of cancer patients who use complementary therapies. Psychooncology 14:187–195PubMedCrossRef
Zurück zum Zitat Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309(6947):86–89PubMedCentralPubMedCrossRef Downer SM, Cody MM, McCluskey P, Wilson PD, Arnott SJ, Lister TA, Slevin ML (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. BMJ 309(6947):86–89PubMedCentralPubMedCrossRef
Zurück zum Zitat Eschiti VS (2007) Lesson from comparison of CAM use by women with female-specific cancers to others: it‘s time to focus on interaction risks with CAM therapies. Integr Cancer Ther 6:313–344PubMedCrossRef Eschiti VS (2007) Lesson from comparison of CAM use by women with female-specific cancers to others: it‘s time to focus on interaction risks with CAM therapies. Integr Cancer Ther 6:313–344PubMedCrossRef
Zurück zum Zitat Frenkel M, Ben-Arye E, Cohen L (2010) Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 9:177–185PubMedCrossRef Frenkel M, Ben-Arye E, Cohen L (2010) Communication in cancer care: discussing complementary and alternative medicine. Integr Cancer Ther 9:177–185PubMedCrossRef
Zurück zum Zitat Gilmour J, Harrison C, Asadi L, Cohen MH, Vohra S (2011) Informed consent: advising patients and parents about complementary and alternative medicine therapies. Pediatrics 128(Suppl 4):S187–S192PubMedCrossRef Gilmour J, Harrison C, Asadi L, Cohen MH, Vohra S (2011) Informed consent: advising patients and parents about complementary and alternative medicine therapies. Pediatrics 128(Suppl 4):S187–S192PubMedCrossRef
Zurück zum Zitat Hann D, Baker F, Denniston M, Entrekin N (2005) Long-term breast cancer survivors’ use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther 4:14–20PubMedCrossRef Hann D, Baker F, Denniston M, Entrekin N (2005) Long-term breast cancer survivors’ use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther 4:14–20PubMedCrossRef
Zurück zum Zitat Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R, Tonn JC (2010) Complementary therapy use in patients with glioma: an observational study. Long-term breast cancer survivors’ use of complementary therapies. Neurology 75:2229–2235PubMedCrossRef Heese O, Schmidt M, Nickel S, Berger H, Goldbrunner R, Tonn JC (2010) Complementary therapy use in patients with glioma: an observational study. Long-term breast cancer survivors’ use of complementary therapies. Neurology 75:2229–2235PubMedCrossRef
Zurück zum Zitat Huebner J, Muecke R, Muenstedt K, Micke O (2012) Kritische analyse der Internetseiten der Gesellschaft für Biologische Krebsabwehr. Onkologe 18:908–914CrossRef Huebner J, Muecke R, Muenstedt K, Micke O (2012) Kritische analyse der Internetseiten der Gesellschaft für Biologische Krebsabwehr. Onkologe 18:908–914CrossRef
Zurück zum Zitat Micke O, Bruns F, Glatzel M, Schönekaes K, Micke P, Mücke R, Büntzel J (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:22–30 Micke O, Bruns F, Glatzel M, Schönekaes K, Micke P, Mücke R, Büntzel J (2009) Predictive factors for the use of complementary and alternative medicine (CAM) in radiation oncology. Eur J Integr Med 1:22–30
Zurück zum Zitat Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R (2010) Complementary and alternative medicine in lung cancer patients: a neglected phenomenon? Front Radiat Ther Oncol 42:198–205PubMedCrossRef Micke O, Buntzel J, Kisters K, Schafer U, Micke P, Mucke R (2010) Complementary and alternative medicine in lung cancer patients: a neglected phenomenon? Front Radiat Ther Oncol 42:198–205PubMedCrossRef
Zurück zum Zitat Miller PE, Vasey JJ, Short PF, Hartman TJ (2009) Dietary supplement use in adult cancer survivors. Oncol Nurs Forum 36:61–68PubMedCrossRef Miller PE, Vasey JJ, Short PF, Hartman TJ (2009) Dietary supplement use in adult cancer survivors. Oncol Nurs Forum 36:61–68PubMedCrossRef
Zurück zum Zitat Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663PubMedCrossRef Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V (2005) Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16:655–663PubMedCrossRef
Zurück zum Zitat Muenstedt K, Entezami A, Wartenberg A, Kullmer U (2000) The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 36:2090–2095CrossRef Muenstedt K, Entezami A, Wartenberg A, Kullmer U (2000) The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 36:2090–2095CrossRef
Zurück zum Zitat Muenstedt K, Harren H, von Georgi R (2011) Complementary and Alternative Medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. Evid Based Complement Alternative Med. doi:10.1093/ecam/nen079 Muenstedt K, Harren H, von Georgi R (2011) Complementary and Alternative Medicine: comparison of current knowledge, attitudes and interest among German medical students and doctors. Evid Based Complement Alternative Med. doi:10.​1093/​ecam/​nen079
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE (2000) Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18:2505–2514PubMed
Zurück zum Zitat Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12:90–98PubMedCrossRef Robinson A, McGrail MR (2004) Disclosure of CAM use to medical practitioners: a review of qualitative and quantitative studies. Complement Ther Med 12:90–98PubMedCrossRef
Zurück zum Zitat Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the women‘s healthy eating and living study. Integr Cancer Ther 7:122–127PubMedCentralPubMedCrossRef Saxe GA, Madlensky L, Kealey S, Wu DP, Freeman KL, Pierce JP (2008) Disclosure to physicians of CAM use by breast cancer patients: findings from the women‘s healthy eating and living study. Integr Cancer Ther 7:122–127PubMedCentralPubMedCrossRef
Zurück zum Zitat Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89:873–880PubMedCrossRef Sollner W, Maislinger S, DeVries A, Steixner E, Rumpold G, Lukas P (2000) Use of complementary and alternative medicine by cancer patients is not associated with perceived distress or poor compliance with standard treatment but with active coping behavior: a survey. Cancer 89:873–880PubMedCrossRef
Zurück zum Zitat Thanner M (2010) Geld oder Glaube? Warum Schulmediziner alternative Heilverfahren anbieten. In: Becker R, Sertel S, Stassen-Rapp I, Walburg I (Hg.) „Neue“Wege in der Medizin: Alternativmedizin – Fluch oder Segen? Heidelberg Thanner M (2010) Geld oder Glaube? Warum Schulmediziner alternative Heilverfahren anbieten. In: Becker R, Sertel S, Stassen-Rapp I, Walburg I (Hg.) „Neue“Wege in der Medizin: Alternativmedizin – Fluch oder Segen? Heidelberg
Zurück zum Zitat Trimborn A, Senf B, Muenstedt K, Buentzel J, Micke O, Muecke R, Prott FJ, Wicker S, Huebner J (2013) Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol 24:2641–2645PubMedCrossRef Trimborn A, Senf B, Muenstedt K, Buentzel J, Micke O, Muecke R, Prott FJ, Wicker S, Huebner J (2013) Attitude of employees of a university clinic to complementary and alternative medicine in oncology. Ann Oncol 24:2641–2645PubMedCrossRef
Zurück zum Zitat Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Serve H, Huebner J (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139:357–365PubMedCrossRef Zeller T, Muenstedt K, Stoll C, Schweder J, Senf B, Ruckhaeberle E, Serve H, Huebner J (2013) Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center. J Cancer Res Clin Oncol 139:357–365PubMedCrossRef
Metadaten
Titel
Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients
verfasst von
A. C. Conrad
K. Muenstedt
O. Micke
F. J. Prott
R. Muecke
J. Huebner
Publikationsdatum
01.07.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 7/2014
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-014-1656-9

Weitere Artikel der Ausgabe 7/2014

Journal of Cancer Research and Clinical Oncology 7/2014 Zur Ausgabe

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.